The Propagation, Quantification, and Storage of Vesicular Stomatitis Virus.


Journal

Current protocols in microbiology
ISSN: 1934-8533
Titre abrégé: Curr Protoc Microbiol
Pays: United States
ID NLM: 101257113

Informations de publication

Date de publication:
09 2020
Historique:
entrez: 25 8 2020
pubmed: 25 8 2020
medline: 26 5 2021
Statut: ppublish

Résumé

Vesicular stomatitis virus (VSV) is the prototypical member of the Rhabdoviridae family of negative-sense single-stranded RNA viruses. This virus has been used as a powerful model system for decades and is currently being used as a vaccine platform and an oncolytic agent. Here, we present methods to propagate, quantitate, and store VSV. We also review the proper safety protocol for the handling of VSV, which is classified as a Biosafety Level 2 pathogen by the United States Centers for Disease Control and Prevention. © 2020 Wiley Periodicals LLC. Basic Protocol 1: Generation, purification, and storage of vesicular stomatitis virus stocks Basic Protocol 2: Quantification of vesicular stomatitis virus by plaque assay Support Protocol: Propagation of Vero cells.

Identifiants

pubmed: 32833351
doi: 10.1002/cpmc.110
pmc: PMC7449588
mid: NIHMS1617011
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e110

Subventions

Organisme : NIAID NIH HHS
ID : R15 AI058969
Pays : United States

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

J Gen Virol. 2012 Dec;93(Pt 12):2529-2545
pubmed: 23052398
Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8388-92
pubmed: 7667300
Int J Clin Exp Med. 2014 May 15;7(5):1204-13
pubmed: 24995075
J Virol. 2002 Jan;76(2):895-904
pubmed: 11752178
Front Oncol. 2020 Apr 16;10:475
pubmed: 32373515
J Virol. 2013 Sep;87(18):10283-94
pubmed: 23864625
Curr Protoc Microbiol. 2016 Nov 18;43:15D.4.1-15D.4.16
pubmed: 27858969
Vaccine X. 2019 Jan 29;1:100009
pubmed: 31384731
Sci Transl Med. 2015 Dec 9;7(317):317ps24
pubmed: 26659569
Rev Med Virol. 2018 Nov;28(6):e2008
pubmed: 30209859
N Engl J Med. 2017 Jan 26;376(4):330-341
pubmed: 25830322
Hum Vaccin Immunother. 2018;14(9):2107-2113
pubmed: 29757706
MethodsX. 2020 Feb 20;7:100806
pubmed: 32195130
J Vis Exp. 2014 Nov 04;(93):e52065
pubmed: 25407402
J Virol. 2010 Apr;84(7):3280-6
pubmed: 20032173
J Comp Neurol. 2015 Aug 1;523(11):1639-63
pubmed: 25688551

Auteurs

Alaa A Abdelmageed (AA)

Thomas H. Gosnell School of Life Sciences, Rochester Institute of Technology, Rochester, New York.

Maureen C Ferran (MC)

Thomas H. Gosnell School of Life Sciences, Rochester Institute of Technology, Rochester, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH